Skip to main content
Equibles
KYTX logo

KYTX · Kyverna Therapeutics, Inc. · Debt

Track KYTX — free

Use KYTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KYTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.63 +0.36 (+6.83%) At close · Oct 27
Russell 2000 member Rebalance outlook locked
Market Cap
$325.91M
Shares
61.84M
Volume · Oct 27 916.67K Avg daily vol (3M) 830.29K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current finance lease liabilities 2026-06-30 USD 126,000 10-Q filed 2026-08-11
Current operating lease liabilities 2026-06-30 USD 1,400,000 10-Q filed 2026-08-11
Noncurrent debt carrying amount 2026-06-30 USD 24,883,000 10-Q filed 2026-08-11
Noncurrent operating lease liabilities 2026-06-30 USD 6,589,000 10-Q filed 2026-08-11
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1994702 CUSIP 501976104 13F (30d) 13 filings 13 filers Visit website Investor relations